DAEWON PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 003220 for the last quarter is 156.83 B KRW, and it's 13.68% higher compared to the previous quarter. The net income of Q3 24 is 6.79 B KRW.